The company's IPO committee has finalised allocation of 60,70,150 equity shares to 11 anchor investors at Rs 248 apiece, also the upper price band for the offer, Shalby informed to the stock exchanges.
At this price, the total amount works out to be Rs 150.54 crore, it added.
Among the anchor investors are Goldman Sachs, Citigroup, Reliance Nippon Life Insurance Company, Nomura and SBI Life Insurance Company.
Shalby's initial public offer (IPO) will open for public subscription tomorrow and close on December 7.
Also Read
The price band has been fixed at Rs 245-248 per share. At the upper end, the public issue would fetch Rs 504 crore.
Proceeds of the IPO will be utilised towards repayment of borrowings availed by the company besides purchasing medical equipment for existing, recently set-up as well as upcoming hospitals.
In the recent months, healthcare services firms Alkem Laboratories, Dr Lal Pathlabs, Narayana Hrudayalaya, Thyrocare and Eris Lifesciences have tapped the primary market through IPO route.
Disclaimer: No Business Standard Journalist was involved in creation of this content